-
1
-
-
77952007543
-
Mammalian target of rapamycin (mTOR): Conducting thecellular signaling symphony
-
Foster KG, Fingar DC. Mammalian target of rapamycin (mTOR): conducting thecellular signaling symphony. J Biol Chem 2010; 285: 14071-14077.
-
(2010)
J Biol Chem
, vol.285
, pp. 14071-14077
-
-
Foster, K.G.1
Fingar, D.C.2
-
2
-
-
78650239404
-
Functions and regulation of the 70kDa ribosomal S6 kinases
-
Fenton TR, Gout IT. Functions and regulation of the 70kDa ribosomal S6 kinases.Int J Biochem Cell Biol 2011; 43: 47-59.
-
(2011)
Int J Biochem Cell Biol
, vol.43
, pp. 47-59
-
-
Fenton, T.R.1
Gout, I.T.2
-
3
-
-
67349217986
-
Molecular mechanisms of mTOR-mediated translational control
-
Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control.Nat Rev Mol Cell Biol 2009; 10: 307-318.
-
(2009)
Nat Rev Mol Cell Biol
, vol.10
, pp. 307-318
-
-
Ma, X.M.1
Blenis, J.2
-
4
-
-
0026659046
-
Rapamycin-FKBP specifically blocksgrowth-dependent activation of and signaling by the 70 kd S6 protein kinases
-
Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specifically blocksgrowth-dependent activation of and signaling by the 70 kd S6 protein kinases.Cell 1992; 69: 1227-1236.
-
(1992)
Cell
, vol.69
, pp. 1227-1236
-
-
Chung, J.1
Kuo, C.J.2
Crabtree, G.R.3
Blenis, J.4
-
5
-
-
0032538890
-
Disruption of thep70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functionalS6 kinase
-
Shima H, Pende M, Chen Y, Fumagalli S, Thomas G, Kozma SC. Disruption of thep70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functionalS6 kinase. EMBO J 1998; 17: 6649-6659.
-
(1998)
EMBO J
, Issue.17
, pp. 6649-6659
-
-
Shima, H.1
Pende, M.2
Chen, Y.3
Fumagalli, S.4
Thomas, G.5
Kozma, S.C.6
-
7
-
-
65249190250
-
S6 kinase 1regulates estrogen receptor alpha in control of breast cancer cell proliferation
-
Yamnik RL, Digilova A, Davis DC, Brodt ZN, Murphy CJ, Holz MK. S6 kinase 1regulates estrogen receptor alpha in control of breast cancer cell proliferation.J Biol Chem 2009; 284: 6361-6369.
-
(2009)
J Biol Chem
, vol.284
, pp. 6361-6369
-
-
Yamnik, R.L.1
Digilova, A.2
Davis, D.C.3
Brodt, Z.N.4
Murphy, C.J.5
Holz, M.K.6
-
8
-
-
34547574720
-
A new mutational AKTivation in the PI3K pathway
-
Brugge J, Hung MC, Mills GB. A new mutational AKTivation in the PI3K pathway.Cancer Cell 2007; 12: 104-107.
-
(2007)
Cancer Cell
, vol.12
, pp. 104-107
-
-
Brugge, J.1
Hung, M.C.2
Mills, G.B.3
-
9
-
-
0034596364
-
Detectingactivation of ribosomal protein S6 kinase by complementary DNA and tissuemicroarray analysis
-
Barlund M, Forozan F, Kononen J, Bubendorf L, Chen Y, Bittner ML et al. Detectingactivation of ribosomal protein S6 kinase by complementary DNA and tissuemicroarray analysis. J Natl Cancer Inst 2000; 92: 1252-1259.
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 1252-1259
-
-
Barlund, M.1
Forozan, F.2
Kononen, J.3
Bubendorf, L.4
Chen, Y.5
Bittner, M.L.6
-
10
-
-
14344280240
-
Comprehensive copy number and gene expression profiling of the 17q23amplicon in human breast cancer
-
Monni O, Barlund M, Mousses S, Kononen J, Sauter G, Heiskanen M et al.Comprehensive copy number and gene expression profiling of the 17q23amplicon in human breast cancer. Proc Natl Acad Sci USA 2001; 98: 5711-5716.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 5711-5716
-
-
Monni, O.1
Barlund, M.2
Mousses, S.3
Kononen, J.4
Sauter, G.5
Heiskanen, M.6
-
11
-
-
0033119602
-
Localization of PS6K tochromosomal region 17q23 and determination of its amplification in breastcancer
-
Couch FJ, Wang XY, Wu GJ, Qian J, Jenkins RB, James CD. Localization of PS6K tochromosomal region 17q23 and determination of its amplification in breastcancer. Cancer Res 1999; 59: 1408-1411.
-
(1999)
Cancer Res
, vol.59
, pp. 1408-1411
-
-
Couch, F.J.1
Wang, X.Y.2
Wu, G.J.3
Qian, J.4
Jenkins, R.B.5
James, C.D.6
-
13
-
-
65549165975
-
Genetic alterationsand oncogenic pathways associated with breast cancer subtypes
-
Hu X, Stern HM, Ge L, O'Brien C, Haydu L, Honchell CD et al. Genetic alterationsand oncogenic pathways associated with breast cancer subtypes. Mol Cancer Res2009; 7: 511-522.
-
(2009)
Mol Cancer Res
, vol.7
, pp. 511-522
-
-
Hu, X.1
Stern, H.M.2
Ge, L.3
O'Brien, C.4
Haydu, L.5
Honchell, C.D.6
-
14
-
-
2442534048
-
Overexpression of P70 S6 kinase protein is associatedwith increased risk of locoregional recurrence in node-negative premenopausalearly breast cancer patients
-
van der Hage JA, van den Broek LJ, Legrand C, Clahsen PC, Bosch CJ,Robanus-Maandag EC et al. Overexpression of P70 S6 kinase protein is associatedwith increased risk of locoregional recurrence in node-negative premenopausalearly breast cancer patients. Br J Cancer 2004; 90: 1543-1550.
-
(2004)
Br J Cancer
, vol.90
, pp. 1543-1550
-
-
Van Der Hage, J.A.1
Van Den Broek, L.J.2
Legrand, C.3
Clahsen, P.C.4
Bosch, C.J.5
Robanus-Maandag, E.C.6
-
15
-
-
0026557343
-
Systemic treatment of earlybreast cancer by hormonal Cytotoxic or immune therapy 133 randomised trialsinvolving 31,000 recurrences and 24,000 deaths among 75,000 women
-
Early Breast Cancer Trialists' Collaborative Group
-
Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of earlybreast cancer by hormonal Cytotoxic or immune therapy 133 randomised trialsinvolving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet1992; 339: 1-15.
-
(1992)
Lancet
, vol.339
, pp. 1-15
-
-
-
16
-
-
2942565669
-
Overcoming endocrine therapy resistance by signal transductioninhibition
-
Ellis M. Overcoming endocrine therapy resistance by signal transductioninhibition. Oncologist 2004; 9(Suppl 3): 20-26.
-
(2004)
Oncologist
, vol.9
, Issue.SUPPL. 3
, pp. 20-26
-
-
Ellis, M.1
-
17
-
-
33646546654
-
Genomic alterationsidentified by array comparative genomic hybridization as prognostic markers intamoxifen-treated estrogen receptor-positive breast cancer
-
Han W, Han MR, Kang JJ, Bae JY, Lee JH, Bae YJ et al. Genomic alterationsidentified by array comparative genomic hybridization as prognostic markers intamoxifen-treated estrogen receptor-positive breast cancer. BMC Cancer 2006;6: 92.
-
(2006)
BMC Cancer
, vol.6
, pp. 92
-
-
Han, W.1
Han, M.R.2
Kang, J.J.3
Bae, J.Y.4
Lee, J.H.5
Bae, Y.J.6
-
18
-
-
65949105732
-
Copy numberalterations that predict metastatic capability of human breast cancer
-
Zhang Y, Martens JW, Yu JX, Jiang J, Sieuwerts AM, Smid M et al. Copy numberalterations that predict metastatic capability of human breast cancer. Cancer Res2009; 69: 3795-3801.
-
(2009)
Cancer Res
, vol.69
, pp. 3795-3801
-
-
Zhang, Y.1
Martens, J.W.2
Yu, J.X.3
Jiang, J.4
Sieuwerts, A.M.5
Smid, M.6
-
19
-
-
71549166007
-
MTOR/S6K1 and MAPK/RSK signaling pathways coordinatelyregulate estrogen receptor alpha serine 167 phosphorylation
-
Yamnik RL, Holz MK. mTOR/S6K1 and MAPK/RSK signaling pathways coordinatelyregulate estrogen receptor alpha serine 167 phosphorylation. FEBS Lett 2010;584: 124-128.
-
(2010)
FEBS Lett
, vol.584
, pp. 124-128
-
-
Yamnik, R.L.1
Holz, M.K.2
-
20
-
-
79952135852
-
The IGF pathway regulates ERalphathrough A S6K1-dependent mechanism in breast cancer cells
-
Becker MA, Ibrahim YH, Cui X, Lee AV, Yee D. The IGF pathway regulates ERalphathrough a S6K1-dependent mechanism in breast cancer cells. Mol Endocrinol2011; 25: 516-528.
-
(2011)
Mol Endocrinol
, vol.25
, pp. 516-528
-
-
Becker, M.A.1
Ibrahim, Y.H.2
Cui, X.3
Lee, A.V.4
Yee, D.5
-
21
-
-
42149103735
-
Genomicanalysis of estrogen cascade reveals histone variant H2A.Z associated with breastcancer progression
-
Hua S, Kallen CB, Dhar R, Baquero MT, Mason CE, Russell BA et al. Genomicanalysis of estrogen cascade reveals histone variant H2A.Z associated with breastcancer progression. Mol Syst Biol 2008; 4: 188.
-
(2008)
Mol Syst Biol
, vol.4
, pp. 188
-
-
Hua, S.1
Kallen, C.B.2
Dhar, R.3
Baquero, M.T.4
Mason, C.E.5
Russell, B.A.6
-
22
-
-
1342308232
-
Anatomy of the estrogenresponse element
-
Gruber CJ, Gruber DM, Gruber IM, Wieser F, Huber JC. Anatomy of the estrogenresponse element. Trends Endocrinol Metab 2004; 15: 73-78.
-
(2004)
Trends Endocrinol Metab
, vol.15
, pp. 73-78
-
-
Gruber, C.J.1
Gruber, D.M.2
Gruber, I.M.3
Wieser, F.4
Huber, J.C.5
-
23
-
-
0030832993
-
Effects of multipleestrogen responsive elements, their spacing, and location on estrogen responseof reporter genes
-
Sathya G, Li W, Klinge CM, Anolik JH, Hilf R, Bambara RA. Effects of multipleestrogen responsive elements, their spacing, and location on estrogen responseof reporter genes. Mol Endocrinol 1997; 11: 1994-2003.
-
(1997)
Mol Endocrinol
, vol.11
, pp. 1994-2003
-
-
Sathya, G.1
Li, W.2
Klinge, C.M.3
Anolik, J.H.4
Hilf, R.5
Bambara, R.A.6
-
24
-
-
34447130861
-
Positive crossregulatoryloop ties GATA-3 to estrogen receptor alpha expression in breastcancer
-
Eeckhoute J, Keeton EK, Lupien M, Krum SA, Carroll JS, Brown M. Positive crossregulatoryloop ties GATA-3 to estrogen receptor alpha expression in breastcancer. Cancer Res 2007; 67: 6477-6483.
-
(2007)
Cancer Res
, vol.67
, pp. 6477-6483
-
-
Eeckhoute, J.1
Keeton, E.K.2
Lupien, M.3
Krum, S.A.4
Carroll, J.S.5
Brown, M.6
-
25
-
-
78650185393
-
Estrogen-InducedAurora Kinase-A (AURKA) gene expression is activated by GATA-3 in estrogenreceptor-positive breast cancer cells
-
Jiang S, Katayama H, Wang J, Li S, Hong Y, Radvanyi L et al. Estrogen-InducedAurora Kinase-A (AURKA) gene expression is activated by GATA-3 in estrogenreceptor-positive breast cancer cells. Hormones Cancer 2010; 1: 11-20.
-
Hormones Cancer
, vol.2010
, Issue.1
, pp. 11-20
-
-
Jiang, S.1
Katayama, H.2
Wang, J.3
Li, S.4
Hong, Y.5
Radvanyi, L.6
-
26
-
-
0034680102
-
Molecularportraits of human breast tumours
-
Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al. Molecularportraits of human breast tumours. Nature 2000; 406: 747-752.
-
(2000)
Nature
, vol.406
, pp. 747-752
-
-
Perou, C.M.1
Sorlie, T.2
Eisen, M.B.3
Van De Rijn, M.4
Jeffrey, S.S.5
Rees, C.A.6
-
27
-
-
2442670465
-
About GATA3, HNF3A, and XBP1, three genes co-expressedwith the oestrogen receptor-alpha gene (ESR1) in breast cancer
-
Lacroix M, Leclercq G. About GATA3, HNF3A, and XBP1, three genes co-expressedwith the oestrogen receptor-alpha gene (ESR1) in breast cancer. Mol CellEndocrinol 2004; 219: 1-7.
-
(2004)
Mol CellEndocrinol
, vol.219
, pp. 1-7
-
-
Lacroix, M.1
Leclercq, G.2
-
28
-
-
33750442923
-
Genome-wideanalysis of estrogen receptor binding sites
-
Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J et al. Genome-wideanalysis of estrogen receptor binding sites. Nat Genet 2006; 38: 1289-1297.
-
(2006)
Nat Genet
, vol.38
, pp. 1289-1297
-
-
Carroll, J.S.1
Meyer, C.A.2
Song, J.3
Li, W.4
Geistlinger, T.R.5
Eeckhoute, J.6
-
29
-
-
34347345081
-
Whole-genomecartography of estrogen receptor alpha binding sites
-
Lin CY, Vega VB, Thomsen JS, Zhang T, Kong SL, Xie M et al. Whole-genomecartography of estrogen receptor alpha binding sites. PLoS Genet 2007; 3: e87.
-
(2007)
PLoS Genet
, vol.3
-
-
Lin, C.Y.1
Vega, V.B.2
Thomsen, J.S.3
Zhang, T.4
Kong, S.L.5
Xie, M.6
-
30
-
-
57349173558
-
AKT alters genome-wide estrogen receptor alpha binding and impacts estrogensignaling in breast cancer
-
Bhat-Nakshatri P, Wang G, Appaiah H, Luktuke N, Carroll JS, Geistlinger TR et al.AKT alters genome-wide estrogen receptor alpha binding and impacts estrogensignaling in breast cancer. Mol Cell Biol 2008; 28: 7487-7503.
-
(2008)
Mol Cell Biol
, vol.28
, pp. 7487-7503
-
-
Bhat-Nakshatri, P.1
Wang, G.2
Appaiah, H.3
Luktuke, N.4
Carroll, J.S.5
Geistlinger, T.R.6
-
31
-
-
70449103609
-
An oestrogenreceptor-alpha-bound human chromatin interactome
-
Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, Mohamed YB et al. An oestrogenreceptor-alpha-bound human chromatin interactome. Nature 2009; 462: 58-64.
-
(2009)
Nature
, vol.462
, pp. 58-64
-
-
Fullwood, M.J.1
Liu, M.H.2
Pan, Y.F.3
Liu, J.4
Xu, H.5
Mohamed, Y.B.6
-
32
-
-
15844388060
-
Estrogen receptors and their downstream targets in cancer
-
Ikeda K, Inoue S. Estrogen receptors and their downstream targets in cancer. ArchHistol Cytol 2004; 67: 435-442.
-
(2004)
ArchHistol Cytol
, vol.67
, pp. 435-442
-
-
Ikeda, K.1
Inoue, S.2
-
33
-
-
66849136781
-
Phase II randomized study of neoadjuvant everolimus plus letrozole comparedwith placebo plus letrozole in patients with estrogen receptor-positive breastcancer
-
Baselga J, Semiglazov V, van Dam P, Manikhas A, Bellet M, Mayordomo J et al.Phase II randomized study of neoadjuvant everolimus plus letrozole comparedwith placebo plus letrozole in patients with estrogen receptor-positive breastcancer. J Clin Oncol 2009; 27: 2630-2637.
-
(2009)
J Clin Oncol
, vol.27
, pp. 2630-2637
-
-
Baselga, J.1
Semiglazov, V.2
Van Dam, P.3
Manikhas, A.4
Bellet, M.5
Mayordomo, J.6
-
34
-
-
79960836840
-
Are we missing the mTOR target in breast cancer?
-
Johnston SR. Are we missing the mTOR target in breast cancer? Breast Cancer ResTreat 2011; 128: 607-611.
-
(2011)
Breast Cancer ResTreat
, vol.128
, pp. 607-611
-
-
Johnston, S.R.1
-
35
-
-
71749119589
-
Globalanalysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 andpoly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells
-
Frizzell KM, Gamble MJ, Berrocal JG, Zhang T, Krishnakumar R, Cen Y et al. Globalanalysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 andpoly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells. J Biol Chem2009; 284: 33926-33938.
-
(2009)
J Biol Chem
, vol.284
, pp. 33926-33938
-
-
Frizzell, K.M.1
Gamble, M.J.2
Berrocal, J.G.3
Zhang, T.4
Krishnakumar, R.5
Cen, Y.6
|